Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+
© Doloff et al; licensee BioMed Central Ltd. 2010
Received: 2 June 2010
Accepted: 13 September 2010
Published: 13 September 2010
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|2 Jun 2010||Submitted||Original manuscript|
|4 Aug 2010||Reviewed||Reviewer Report - Peter Searle|
|10 Aug 2010||Reviewed||Reviewer Report - Donald Buchsbaum|
|16 Aug 2010||Reviewed||Reviewer Report - Matthias Renner|
|23 Aug 2010||Author responded||Author comments - Joshua Doloff|
|Resubmission - Version 2|
|23 Aug 2010||Submitted||Manuscript version 2|
|25 Aug 2010||Reviewed||Reviewer Report - Matthias Renner|
|31 Aug 2010||Reviewed||Reviewer Report - Peter Searle|
|12 Sep 2010||Author responded||Author comments - Joshua Doloff|
|Resubmission - Version 3|
|12 Sep 2010||Submitted||Manuscript version 3|
|13 Sep 2010||Editorially accepted|
|13 Sep 2010||Article published||10.1186/1471-2407-10-487|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.